Systemic Lupus Erythmatosus

You might also like

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 25

Nursing Care of the Client with

Connective Tissue Disease

Systemic Lupus
Systemic Sclerosis

Polymyositis
Systemic Lupus Erythmatosus

Multisystem Inflammatory Disease


Etiology and Pathophysiology
 Etiology – unknown
 Genetic predisposition
 Hormones

 Environmental factors

 Triggers:
 Infection
 Certain medications
Overaggressive Antibody Response

 Immune complexes deposited in


basement membranes of capillaries:
 Kidneys

 Heart

 Skin

 Brain

 Joints

* Specific symptoms of SLE depend on


which cells or organs are involved
Manifestations & Complications
 Variable depending on severity
 Any organ(s) may be affected
 Most commonly affected:
 Skin
 Muscle
 Lungs
 Heart
 Nervous system
 Kidneys
Manifestations & Complications
 Skin
 Butterfly rash – 50% of patients
 Ulcers – mouth or nose
 Alopecia
 Musculoskeletal
 Polyarthralgia – 90% of patients
 Non-erosive arthritis
 Cardiopulmonary
 Tachypnea & cough
 Arrhythmias
 Accelerates CAD
Manifestations & Complications
 Renal problems – 50% of clients within
one year
 Mild proteinuria to glomerulonephritis
 Nervous system
 Seizures
 Disordered thought processes
 Disorientation
 Memory deficits
 Depression
 Psychosis
Manifestations & Complications
 Hematological problems
 Anemia

 Mildleukopenia
 Thrombocytopenia

 Infection
 Immunosuppresive effect of anti-
inflammatory drugs
 Defects in ability to phagocytize
invading bacteria
Diagnosis of SLE
 No specific diagnostic test
 Four or more of criteria are present
serially or simultaneously
 Presence of criteria are not
definitive for diagnosis
 “rule-out” other disease processes
Drug Therapy
 NSAID’s
 hydroxychloroquine (Plaquenil)
 corticosteroids – especially during
severe exacerbations of polyarthritis
 methotrexate
 azathioprine (Imuran)
Nursing Care
 Assess severity of symptoms: fever,
joint pain and limitations of
movement, fatigability
 Weight and I&O – risk of fluid
overload:
 renal failure
 corticosteroid therapy
Nursing Care
 Observe S/S bleeding
 Changes in vital signs
 Bruising
 Petechiae
 Tarry stools
 Pallor
 Assess neuro status
 Visual disturbances
 Mental status
 Seizures
 Numbness, tingling, weakness of extremities
Patient Education
 Avoid triggers: sun, infections,
emotional stress, etc.
 Pre-conception counseling
 Correct use of medication(s) and
importance of compliance
 Disease complications are “hidden”;
physical limitations are not obvious
Patient Education

Web site co-sponsored by NIH and


National Institute of Arthritis and
Musculoskeletal and Skin Diseases

http://www.niams.nih.gov/hi/topics/lupus
Systemic Sclerosis
 Fibrotic, degenerative changes
 Skin thickening/tightening
 Localized vs. systemic
 Causes:
 Immune dysfunction
 Vascular abnormalities

 Environmental exposure
Systemic Sclerosis
 Collagen is over produced
 CREST syndrome:
 Calcinosis

 Raynaud’s phenomenon
 Esophageal dysfunction

 Sclerodactyly

 Telangiectasia
Systemic Sclerosis
 Internal organ involvement
 Esophageal fibrosis
 Lung involvement

 Heart disease (CHF)

 Kidney disease with malignant


hypertension
Nursing and Collaborative Care
 Goal of medical regimen:
 Prevent complications of involved
organs
 Medications:
 Corticosteroids
 Vasodilators (Raynaud’s, hypertension)

 H2 receptor blocker or proton pump


inhibitor (GI symptoms)
 Physical therapy
 Nursing care
Nursing Care
 Assessment:
 Joint ROM
 Respiratory function

 Nutrition: swallowing, weight, I&O

 Circulation: Raynaud’s

 Body image
Nursing Care
 Nursing Interventions:
 ROM exercises, mouth excursion
 Moist heat/parafifin

 Protect hands and feet:


 Keep warm
 Gloves

 No finger-stick blood testing

 No smoking – vasoconstriction

 Inspect for injury/infection


Nursing Care
 Special attention to oral care
 Nutrition and hydration
 Small, frequent meals
 Carefull/complete chewing

 Dysphagia precautions
 Thickened liquids
 High fowlers 2 hours after eating

 Antacids 45 minutes after eating if


gastric reflux
Resources for clients and
health professionals

http://www.scleroderma.org/
Polymyositis
 Diffuse, inflammatory myopathies of
striated muscle
 Relatively rare
 Produces bilateral weakness of
shoulders, legs, arms and pelvic
girdle
 Joint pain, reddness, inflammation
Collaborative Care
 Patient teaching:
 Prescribed therapies
 Tests
 Importance of follow-up care
 Delay in response to therapy
 Patient safety
 Paced activity
 Physical therapy
 High-dose corticosteroids
 Immunosuppressive drugs
 methotrexate

You might also like